Daniel M Geynisman

11PUBLICATIONS
149CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 29, 2026
Modeling Therapy Sequence for Advanced Cancer: A Microsimulation Approach Leveraging Electronic Health Record Data.

|Sep 11, 2025
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.

Andrea Necchi, Matthew D Galsky, Nazli Dizman

|Jan 06, 2025
Treatment Patterns and Costs Among Patients With Metastatic Renal Cell Carcinoma in the United States: A Real-World Study Using Integrated Claims and Clinical Data.

Daniel M Geynisman, Nathan R Hill, Lisa C Rosenblatt

|Dec 16, 2024
Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1).

Daniel M Geynisman, Philip H Abbosh, Eric Ross

|Jun 12, 2024
Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates.

Uttam Satyal, Henkel Valentine, David Liu

|May 15, 2024
Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-institutional Prospective Cohort Evaluation.

Laura Bukavina, Rashida Ginwala, Mohamed Eltoukhi

Pageof 2

Frequent Collaborators

5 joint publications

Elizabeth R Plimack

3 joint publications

Philip H Abbosh

3 joint publications

Eric Ross

3 joint publications

Philippe E Spiess